William Forbes
Directeur/Bestuurslid bij BEYOND AIR, INC.
Vermogen: 371 898 $ op 31-05-2024
Profiel
William P.
Forbes founded Vivelix Pharmaceuticals, Ltd.
in 2016, where he worked as President & Chief Executive Officer.
Dr. Forbes also currently works at Beyond Air, Inc., as Independent Director from 2018, Beyond Air Ltd., as Director from 2018, Hallux, Inc., as Director from 2018, and Heron Therapeutics, Inc., as Chief Development Officer & Executive VP from 2023.
Dr. Forbes also formerly worked at Salix Pharmaceuticals Ltd., as President-Medical, Research & Development in 2015, Metabasis Therapeutics, Inc., as VP, Clinical Development & Regulator Affairs in 2004, Otsuka America Pharmaceutical, Inc., as Group Leader, Glaxo, Inc., as Senior Clinical Research Scientist, and Trevi Therapeutics, Inc., as Chief Development Officer from 2021 to 2022.
Dr. Forbes received his doctorate degree from Creighton University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
HERON THERAPEUTICS INC
0.06% | 06-06-2024 | 95 374 ( 0.06% ) | 352 884 $ | 31-05-2024 |
BEYOND AIR, INC.
0.03% | 20-06-2024 | 14 855 ( 0.03% ) | 19 014 $ | 31-05-2024 |
Actieve functies van William Forbes
| Bedrijven | Functie | Begin |
|---|---|---|
| BEYOND AIR, INC. | Directeur/Bestuurslid | 13-08-2018 |
| HERON THERAPEUTICS, INC. | Corporate Officer/Principal | 06-06-2023 |
Beyond Air Ltd.
 Beyond Air Ltd. BiotechnologyHealth Technology Beyond Air, Ltd. is a clinical-stage medical device and biopharmaceutical company engaging in the development of nitric oxide generator and delivery system that uses nitric oxide generated from ambient air and delivers precise amounts of nitric oxide to the lungs for the potential treatment of respiratory and other diseases. The company was founded by Yossef Av-Gay, Amir Avniel, and David Greenberg in May 2011 and is headquartered in Rehovot, Israel. | Directeur/Bestuurslid | 01-01-2018 |
Hallux, Inc.
 Hallux, Inc. Pharmaceuticals: MajorHealth Technology Hallux, Inc. provides pharmaceutical services. It develops a new terbinafine dosage form and subungual route of administration for the treatment of onychomycosis. The company was founded by Mark T. Taylor, Jay Edward Birnbaum, Hendrik Arend Kroon and Robert Orr in 2012 and is headquartered in Laguna Hills, CA. | Directeur/Bestuurslid | 01-11-2018 |
Eerdere bekende functies van William Forbes
| Bedrijven | Functie | Einde |
|---|---|---|
| TREVI THERAPEUTICS, INC. | Corporate Officer/Principal | 01-01-2022 |
| SALIX PHARMACEUTICALS, LTD. | Hoofd Techniek/Wetenschap/O&O | 01-06-2015 |
Metabasis Therapeutics, Inc.
 Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | Algemeen Adviseur | 01-01-2004 |
Vivelix Pharmaceuticals, Ltd.
 Vivelix Pharmaceuticals, Ltd. Pharmaceuticals: MajorHealth Technology Vivelix Pharmaceuticals, Ltd. manufactures and sells pharmaceutical products. The private company is based in Hamilton, BM. and has subsidiaries in the United States. The Bermudian company was founded by William P. Forbes. | Algemeen Directeur | - |
Otsuka America Pharmaceutical, Inc.
 Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Otsuka America Pharmaceutical, Inc. manufactures and supplies pharmaceutical products. It develops drugs for neuroscience, cardiovascular, and gastrointestinal treatments. The company was founded in 1989 and is headquartered in Rockville, MD. | Corporate Officer/Principal | - |
Opleiding van William Forbes
| Creighton University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| HERON THERAPEUTICS, INC. | Health Technology |
| TREVI THERAPEUTICS, INC. | Health Technology |
| BEYOND AIR, INC. | Health Technology |
| Bedrijven in privébezit | 7 |
|---|---|
Salix Pharmaceuticals Ltd.
 Salix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Salix Pharmaceuticals Ltd. develops and commercializes prescription drugs and medical devices used in the treatment of gastrointestinal diseases, endocrinology, hepatology, colorectal surgery, and internal medicine. It offers Anusol, Apriso, Colazal, Deflux, Diuril, Fenoglide, MoviPrep, Pepcid, Solesta, and Zegerid. The company was founded by randy W. Hamilton and Lorin K. Johnson in1989 and is headquartered in Bridgewater, NJ. | Health Technology |
Metabasis Therapeutics, Inc.
Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | Health Technology |
Otsuka America Pharmaceutical, Inc.
Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Otsuka America Pharmaceutical, Inc. manufactures and supplies pharmaceutical products. It develops drugs for neuroscience, cardiovascular, and gastrointestinal treatments. The company was founded in 1989 and is headquartered in Rockville, MD. | Health Technology |
| Glaxo, Inc. | |
Beyond Air Ltd.
Beyond Air Ltd. BiotechnologyHealth Technology Beyond Air, Ltd. is a clinical-stage medical device and biopharmaceutical company engaging in the development of nitric oxide generator and delivery system that uses nitric oxide generated from ambient air and delivers precise amounts of nitric oxide to the lungs for the potential treatment of respiratory and other diseases. The company was founded by Yossef Av-Gay, Amir Avniel, and David Greenberg in May 2011 and is headquartered in Rehovot, Israel. | Health Technology |
Hallux, Inc.
Hallux, Inc. Pharmaceuticals: MajorHealth Technology Hallux, Inc. provides pharmaceutical services. It develops a new terbinafine dosage form and subungual route of administration for the treatment of onychomycosis. The company was founded by Mark T. Taylor, Jay Edward Birnbaum, Hendrik Arend Kroon and Robert Orr in 2012 and is headquartered in Laguna Hills, CA. | Health Technology |
Vivelix Pharmaceuticals, Ltd.
Vivelix Pharmaceuticals, Ltd. Pharmaceuticals: MajorHealth Technology Vivelix Pharmaceuticals, Ltd. manufactures and sells pharmaceutical products. The private company is based in Hamilton, BM. and has subsidiaries in the United States. The Bermudian company was founded by William P. Forbes. | Health Technology |
